● Recruiting

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer

Condition: Colorectal Cancer Metastatic · Brain Metastases, Adult · Ras (KRAS or NRAS) Gene Mutation · Sponsor: Blokhin's Russian Cancer Research Center

PhaseN/A

Planned participants30

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

GENCONCOR-1 study is translational research aimed to investigate the concordance of the molecular genetic profile of the primary tumor and brain metastases (BM) of colorectal cancer (CRC). The study was conducted by post hoc analysis of pairs of samples of histological material with determination of the mutational status of genes KRAS, NRAS, BRAF, HER2 and MSI.

This description comes directly from the study's public registry record.

Talk to the study team

David Halafyan, MD · +7(930)928-00-72 · daveupnow@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Blokhin's Russian Cancer Research Center

Moscow, Moscow, Russia

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06449989